Home › U.S. FDA approves Amgen leukemia drug ahead of schedule
 

Keywords :   


U.S. FDA approves Amgen leukemia drug ahead of schedule

2014-12-04 00:02:10| Biotech - Topix.net

U.S. health regulators on Wednesday approved an Amgen Inc drug that helps the immune system fight a rare type of leukemia, more than five months ahead of the expected decision date. The drug, blinatumomab, which will be sold under the brand name Blincyto, was approved to treat a form of acute lymphoblastic leukemia for which there are currently virtually no treatment options.

Tags: drug schedule ahead fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05Online car retailer Cazoo enters administration
21.05Sherwin-Williams Launches Pipeclad Frac-Shun ERC Technology
21.05Kosas Launches Blush Is Life Collection
21.05Avery Dennison receives APR critical guidance for HDPE plastic
21.05RAAA announces two staff promotions
21.05Fiery, Esko, and GIS team up to streamline digital press production
21.05Axalta Announces Partnership with Solera, a Global Leader in Vehicle Lifecycle Management
21.05PPG to Build New Paint and Coatings Manufacturing Facility in Tennessee
More »